APO RESEARCH · REPORT
Travelers Vaccines
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Product & engineering
Understand the product.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Selected research
Industry Research
Travelers Vaccines Industry Research Report 2026
Market perspective
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Read the full market overview
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
Report Scope
This report quantifies the global Travelers Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (k doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Travelers Vaccines Market by Company
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Travelers Vaccines Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Travelers Vaccines Segment by End Users
Tourists
Students
Workers
Others
Travelers Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Travelers Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Travelers Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Travelers Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Travelers Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Travelers Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Yellow Fever Vaccine
- Hepatitis Vaccine
- Cholera Vaccine
- Other
Applications
- Tourists
- Students
- Workers
- Others
Companies covered
- GlaxoSmithKline
- Sanofi Pasteur
- Merck
- Pfizer
- CNBG
- Sanofi Pasteur MSD
- Serum Institute of India
- Biokangtai
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Travelers Vaccines Market Size (2021-2032)
- 2.2.2 Global Travelers Vaccines Sales (2021-2032)
- 2.2.3 Global Travelers Vaccines Market Average Price (2021-2032)
- 2.3 Travelers Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Meningococcal Vaccine
- 2.3.3 Japanese Encephalitis Vaccine
- 2.3.4 Yellow Fever Vaccine
- 2.3.5 Hepatitis Vaccine
- 2.3.6 Cholera Vaccine
- 2.3.7 Other
- 2.4 Travelers Vaccines by End Users
- 2.4.1 Market Value Comparison by End Users (2021 VS 2025 VS 2032)
- 2.4.2 Tourists
- 2.4.3 Students
- 2.4.4 Workers
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Travelers Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Travelers Vaccines Sales (k doses) of Manufacturers (2021-2026)
- 3.3 Global Travelers Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Travelers Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Travelers Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Travelers Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Travelers Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Travelers Vaccines, Established Date
- 3.9 Global Travelers Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GlaxoSmithKline
- 4.1.1 GlaxoSmithKline Company Information
- 4.1.2 GlaxoSmithKline Business Overview
- 4.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
- 4.1.5 GlaxoSmithKline Recent Developments
- 4.2 Sanofi Pasteur
- 4.2.1 Sanofi Pasteur Company Information
- 4.2.2 Sanofi Pasteur Business Overview
- 4.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
- 4.2.5 Sanofi Pasteur Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Travelers Vaccines Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Travelers Vaccines Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 CNBG
- 4.5.1 CNBG Company Information
- 4.5.2 CNBG Business Overview
- 4.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CNBG Travelers Vaccines Product Portfolio
- 4.5.5 CNBG Recent Developments
- 4.6 Sanofi Pasteur MSD
- 4.6.1 Sanofi Pasteur MSD Company Information
- 4.6.2 Sanofi Pasteur MSD Business Overview
- 4.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
- 4.6.5 Sanofi Pasteur MSD Recent Developments
- 4.7 Serum Institute of India
- 4.7.1 Serum Institute of India Company Information
- 4.7.2 Serum Institute of India Business Overview
- 4.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Serum Institute of India Travelers Vaccines Product Portfolio
- 4.7.5 Serum Institute of India Recent Developments
- 4.8 Biokangtai
- 4.8.1 Biokangtai Company Information
- 4.8.2 Biokangtai Business Overview
- 4.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Biokangtai Travelers Vaccines Product Portfolio
- 4.8.5 Biokangtai Recent Developments
5 Global Travelers Vaccines Market Scenario by Region
- 5.1 Global Travelers Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Travelers Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Travelers Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Travelers Vaccines Sales by Region: 2027-2032
- 5.3 Global Travelers Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Travelers Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Travelers Vaccines Revenue by Region: 2027-2032
- 5.4 North America Travelers Vaccines Market Facts & Figures by Country
- 5.4.1 North America Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Travelers Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Travelers Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Travelers Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Travelers Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Travelers Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Travelers Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Travelers Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Travelers Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Travelers Vaccines Market Facts & Figures by Country
- 5.7.1 South America Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Travelers Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Travelers Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Travelers Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Travelers Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Travelers Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Travelers Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Travelers Vaccines Sales by Type (2021-2032) & (k doses)
- 6.1.2 Global Travelers Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Travelers Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Travelers Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Travelers Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Travelers Vaccines Price by Type (2021-2032)
7 Segment by End Users
- 7.1 Global Travelers Vaccines Sales by End Users (2021-2032)
- 7.1.1 Global Travelers Vaccines Sales by End Users (2021-2032) & (k doses)
- 7.1.2 Global Travelers Vaccines Sales Market Share by End Users (2021-2032)
- 7.2 Global Travelers Vaccines Revenue by End Users (2021-2032)
- 7.2.1 Global Travelers Vaccines Sales by End Users (2021-2032) & (US$ Million)
- 7.2.2 Global Travelers Vaccines Revenue Market Share by End Users (2021-2032)
- 7.3 Global Travelers Vaccines Price by End Users (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Travelers Vaccines Value Chain Analysis
- 8.1.1 Travelers Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Travelers Vaccines Production Mode & Process
- 8.2 Travelers Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Travelers Vaccines Distributors
- 8.2.3 Travelers Vaccines Customers
9 Global Travelers Vaccines Analyzing Market Dynamics
- 9.1 Travelers Vaccines Industry Trends
- 9.2 Travelers Vaccines Industry Drivers
- 9.3 Travelers Vaccines Industry Opportunities and Challenges
- 9.4 Travelers Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst